Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Frontiers in Immunology|May 2, 2022
The Human Male Liver Is Predisposed to Inflammation Via Enhanced Myeloid Responses to Inflammatory TriggersAdrian Kuipery, Deeqa Mahamed, Shirin Nkongolo, et al.
Gastroenterology|March 19, 2018
Nonlytic Lymphocytes Engineered to Express Virus-Specific T-Cell Receptors Limit HBV Infection by Activating APOBEC3Sarene Koh, Janine Kah, Christine Y L Tham, et al.
Immunotherapy Advances|August 28, 2023
Lytic efficiency of immunosuppressive drug-resistant armoured T cells against circulating HBV-related HCC in whole bloodMeiyin Lin, Sebastian Chakrit Bhakdi, Damien Tan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 1, 2016
Advanced Design of Dumbbell-shaped Genetic Minimal Vectors Improves Non-coding and Coding RNA ExpressionXiaoou Jiang, Han Yu, Cui Rong Teo, et al.
Ebiomedicine|June 19, 2024
T cell hybrid immunity against SARS-CoV-2 in children: a longitudinal studyMartin Qui, Smrithi Hariharaputran, Shou Kit Hang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 31, 2024
Liver-restricted Type I IFN Signature Precedes Liver Damage in Chronic Hepatitis B Patients Stopping Antiviral TherapyConan Chua, Deeqa Mahamed, Shirin Nkongolo, et al.
JCI Insight|June 15, 2017
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumorsAndrea Pavesi, Anthony T Tan, Sarene Koh, et al.
The Journal of Clinical Investigation|August 8, 2018
PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infectionLoghman Salimzadeh, Nina Le Bert, Charles-A Dutertre, et al.
Vaccine|April 7, 2024
Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccinationChia-Yin Chong, Kai-Qian Kam, Jinyan Zhang, et al.
JHEP Reports : Innovation in Hepatology|August 11, 2021
Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functionsKatie Healy, Andrea Pavesi, Tiphaine Parrot, et al.
Pageof 25